SCHEMBL1597909

SCHEMBL1597909

c1ccc2nc(NCC3CCCCN3)cnc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 3/20 0.48
POLB P06746 2/20 0.47
KDM4E B2RXH2 1/20 0.47
ALDH1A1 P00352 1/20 0.47
GAA P10253 1/20 0.47
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
PRMT5 O14744 1/20 0.45
PDE10A Q9Y233 1/20 0.41
CCNT1 O60563 2/20 0.41
CDK4 P11802 1/20 0.41
IDO1 P14902 2/20 0.40
TDO2 P48775 2/20 0.40
PDGFRB P09619 1/20 0.40
PDGFRA P16234 1/20 0.40
SYK P43405 1/20 0.40
KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1598614 0.85 PRMT5 (0.46) IRAK4POLBCYP1A2CYP3A4CYP2D6
SCHEMBL1596888 0.83 CYP1A2 (0.59) IRAK4POLBKDM4ECYP1A2CYP3A4
SCHEMBL1597743 0.83 CYP1A2 (0.59) IRAK4POLBKDM4ECYP1A2CYP3A4
SCHEMBL1599104 0.82 IDO1 (0.42) IRAK4PRMT5CCNT1CDK4IDO1
SCHEMBL1599109 0.82 IDO1 (0.42) IRAK4PRMT5CCNT1CDK4IDO1
SCHEMBL1598415 0.78 IRAK4 (0.43) IRAK4CCNT1IDO1TDO2
SCHEMBL1598414 0.78 IRAK4 (0.43) IRAK4CCNT1IDO1TDO2
SCHEMBL1597345 0.78 CYP1A2 (0.50) IRAK4POLBCYP1A2CYP3A4CYP2D6
SCHEMBL1598411 0.78 IRAK4 (0.43) IRAK4CCNT1IDO1TDO2
Trifluoroacetic Acid SCHEMBL1596718 0.77 PTPN11 (0.40) IRAK4CYP1A2CYP2D6PRMT5IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7919507-B2 N-aroyl cyclic amines SMITHKLINE BEECHAM LIMITED (GB) 2011-04-05 US disclosed
US-7741329-B2 N-aroyl cyclic amines SMITHKLINE BEECHAM LIMITED (GB) 2010-06-22 US disclosed
US-20090093478-A1 N-AROYL CYCLIC AMINES SMITHKLINE BEECHAM P.I.C. 2009-04-09 US disclosed
US-20090029986-A1 N-AROYL CYCLIC AMINES SMITHKLINE BEECHAM P.L.C. 2009-01-29 US disclosed
US-20090012073-A1 N-AROYL CYCLIC AMINES SMITHKLINE BEECHAM P.L.C. 2009-01-08 US disclosed
US-7432270-B2 N-aroyl cyclic amines SMITHKLINE BEECHAM P.L.C. (GB) 2008-10-07 US disclosed
EP-1385845-B1 N-AROYL CYCLIC AMINES SMITHKLINE BEECHAM PLC (GB) 2008-01-09 EP disclosed
US-20040143115-A1 N-aroyl cyclic amines SMITHKLINE BEECHAM LIMITED (GB) 2004-07-22 US disclosed
EP-1385845-A1 N-AROYL CYCLIC AMINES SMITHKLINE BEECHAM PLC (GB) 2004-02-04 EP disclosed
WO-2002090355-A1 N-AROYL CYCLIC AMINES SMITHKLINE BEECHAM P.L.C. (GB) 2002-11-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012073-A1 N-AROYL CYCLIC AMINES AANAT, MAOA, MAOB IRAK4 4102/4885POLB 1875/4885KDM4E 2204/4885
US-20090093478-A1 N-AROYL CYCLIC AMINES AANAT, MAOA, MAOB IRAK4 4102/4885POLB 1875/4885KDM4E 2204/4885
US-20090029986-A1 N-AROYL CYCLIC AMINES AANAT, MAOA, MAOB IRAK4 4102/4885POLB 1875/4885KDM4E 2204/4885
US-20040143115-A1 N-aroyl cyclic amines HCRTR1, HCRTR2, CNR1 IRAK4 3677/4885POLB 3607/4885KDM4E 1703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.